Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension

Nature Genetics

Volumn 45, Issue 5, 2013, Pages 518-521

  Germain, Marine ^a,b   Eyries, Mélanie ^b,c,d   Montani, David ^e,f,g   Poirier, Odette ^b,c   Girerd, Barbara ^e,f,g   Dorfmüller, Peter ^e,f,g,h   Coulet, Florence ^d   Nadaud, Sophie ^b,c   Maugenre, Svetlana ^b,c   Guignabert, Christophe ^e,f,g   Carpentier, Wassila ^a   Vonk Noordegraaf, Anton ⁱ   Lévy, Marilyne ^j,k   Chaouat, Ari ^l   Lambert, Jean Charles ^m   Bertrand, Marion ^a   Dupuy, Anne Marie ⁿ   Letenneur, Luc ^o   Lathrop, Mark ^p   Amouyel, Philippe ^m,q   De Ravel, Thomy J ^r   Delcroix, Marion ^r,s   Austin, Eric D ^t   Robbins, Ivan M ^t   Hemnes, Anna R ^t   Loyd, James E ^t   Berman Rosenzweig, Erika ^u   Barst, Robyn J ^u   Chung, Wendy K ^u   Simonneau, Gerald ^e,f,g   Trégouët, David A ^a,b   Humbert, Marc ^e,f,g   Soubrier, Florent ^b,c,d   more..

^a SORBONNE UNIVERSITÉ   (France)

^b Institut Cardiométabolisme et Nutrition Pitié Salpêtrière   (France)

^c UPMC Université Paris 6 and INSERM ^*  (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f BICÊTRE HOSPITAL   (France)

^g Universite Paris Sud   (France)

^h CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

ⁱ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^j HÔPITAL NECKER ENFANTS MALADES   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

^l UNIVERSITY HOSPITAL OF NANCY   (France)

^m UNIV LILLE   (France)

ⁿ UNIV MONTPELLIER   (France)

^o UNIVERSITÉ DE BORDEAUX   (France)

^p CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^q LILLE UNIVERSITY HOSPITAL   (France)

^r UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^s UNIVERSITY OF LEUVEN   (Belgium)

^t VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^u Howard Hughes Medical Institute   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BMPR2 PROTEIN; CBLN2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CASE CONTROL STUDY; CELL CULTURE; CHROMOSOME 18Q; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION;

CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOENZYME TECHNIQUES; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY ARTERY; QUANTITATIVE TRAIT LOCI; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84878576691     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2581     Document Type: Article

References (31)

1. Simonneau, G. et al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 54, S43-S54 (2009).
2. Sztrymf, B. et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am. J. Respir. Crit. Care Med. 177, 1377-1383 (2008).
3. Girerd, B. et al. Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension. Respir. Res. 11, 73 (2010).
4. Gaine, S.P. & Rubin, L.J. Primary pulmonary hypertension. Lancet 352, 719-725 (1998).
5. McLaughlin, V.V. & McGoon, M.D. Pulmonary arterial hypertension. Circulation 114, 1417-1431 (2006).
6. Humbert, M. et al. Pulmonary arterial hypertension in France: results from a national registry. Am. J. Respir. Crit. Care Med. 173, 1023-1030 (2006).
7. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
8. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333-338 (2011).
9. Yiangou, Y., Burnet, P., Nikou, G., Chrysanthou, B.J. & Bloom, S.R. Purification and characterisation of cerebellins from human and porcine cerebellum. J. Neurochem. 53, 886-889 (1989).
10. Nilsson, A. et al. Neuropeptidomics of mouse hypothalamus after imipramine treatment reveal somatostatin as a potential mediator of antidepressant effects. Neuropharmacology 62, 347-357 (2012).
11. Miura, E., Iijima, T., Yuzaki, M. & Watanabe, M. Distinct expression of Cbln family mRNAs in developing and adult mouse brains. Eur. J. Neurosci. 24, 750-760 (2006).
12. Matsuda, K. & Yuzaki, M. Cbln family proteins promote synapse formation by regulating distinct neurexin signaling pathways in various brain regions. Eur. J. Neurosci. 33, 1447-1461 (2011).
13. Bottos, A. et al. The synaptic proteins neurexins and neuroligins are widely expressed in the vascular system and contribute to its functions. Proc. Natl. Acad. Sci. USA 106, 20782-20787 (2009).
14. Eichmann, A., Le Noble, F., Autiero, M. & Carmeliet, P. Guidance of vascular and neural network formation. Curr. Opin. Neurobiol. 15, 108-115 (2005).
15. Sitbon, O. et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 111, 3105-3111 (2005).
16. Loyd, J.E., Primm, R.K. & Newman, J.H. Familial primary pulmonary hypertension: clinical patterns. Am. Rev. Respir. Dis. 129, 194-197 (1984).
17. Eyries, M. et al. ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertension. Clin. Genet. 82, 173-179 (2012).
18. 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 22, 316-325 (2003).
19. Allanore, Y. et al. Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet. 7, e1002091 (2011).
20. Germain, M. et al. Genetics of venous thrombosis: insights from a new genome wide association study. PLoS ONE 6, e25581 (2011).
21. Hollingworth, P. et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 43, 429-435 (2011).
22. Saad, M. et al. Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum. Mol. Genet. 20, 615-627 (2011).
23. McGoon, M. et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126, 14S-34S (2004).
24. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
25. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997-1004 (1999).
26. Sasieni, P.D. From genotypes to genes: doubling the sample size. Biometrics 53, 1253-1261 (1997).
27. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22, 719-748 (1959).
28. Guignabert, C. et al. Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22?-targeted overexpression of the serotonin transporter. FASEB J. 23, 4135-4147 (2009).
29. Tu, L. et al. Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 45, 311-322 (2011).
30. Dupuis, M. et al. Profiling of aortic smooth muscle cell gene expression in response to chronic inhibition of nitric oxide synthase in rats. Circulation 110, 867-873 (2004).
31. Montani, D. et al. C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 184, 116-123 (2011).